🟢 Quantum BioPharma is trading 11.38% up today as biotech M&A speculation lifts sector

Quantum BioPharma is trading 11.38% up at $3.23, with biotech-sector strength providing the clearest explanation for the August 6, 2026 move.

• The XBI biotech ETF gained 2.09% as Argenx’s acquisition of Forte Biosciences renewed industry M&A speculation.
• An August 3 update said its Massachusetts General Hospital MS imaging study reached halfway enrollment with encouraging preliminary PET signals.
• No stronger company-specific catalyst was identified for August 6.